Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily ...

Type 2 diabetes can increase your risk of pancreatic cancer, but the amount of time since your diagnosis can affect your risk ...

SGLT-2 inhibitor use vs DPP-4 inhibitor use was associated with lower incidence of epilepsy among patients with type 2 diabetes.

A new study published in the journal of Diabetes Research and Clinical Practice showed that following bariatric surgery, ...

MIND-BODY exercises (MBEs) such as yoga, meditation, and mindfulness are increasingly popular among individuals with type 2 ...

Diabetes insipidus affects the kidneys but does not concern blood sugar control like diabetes mellitus. Learn about the differences and why both are called “diabetes.” ...

Sodium-glucose cotransporter-2 inhibitors (SGLT2i), or gliflozins, are medications used in the treatment of type 2 diabetes ...

A new study published in Health Data Science by researchers at Peking University reveals a concerning rise in the prevalence ...

Polycystic ovarian syndrome (PCOS) is a complex disorder of metabolism, endocrine function, and the reproductive system that affects an estimated 1 in 10 ...

inhibitors is associated with a lower incidence of epilepsy for people with type 2 diabetes mellitus (T2DM), according to results of a study published in Diabetes Care. SGLT-2 inhibitors are a ...